148 related articles for article (PubMed ID: 17332319)
1. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
Moreno-Bueno G; Fernandez-Marcos PJ; Collado M; Tendero MJ; Rodriguez-Pinilla SM; Garcia-Cao I; Hardisson D; Diaz-Meco MT; Moscat J; Serrano M; Palacios J
Cancer Res; 2007 Mar; 67(5):1927-34. PubMed ID: 17332319
[TBL] [Abstract][Full Text] [Related]
2. BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability.
Catasús L; Matias-Guiu X; Machin P; Muñoz J; Prat J
Lab Invest; 1998 Nov; 78(11):1439-44. PubMed ID: 9840618
[TBL] [Abstract][Full Text] [Related]
3. Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype.
Zysman M; Saka A; Millar A; Knight J; Chapman W; Bapat B
Cancer Res; 2002 Jul; 62(13):3663-6. PubMed ID: 12097272
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis.
Saegusa M; Hashimura M; Kuwata T; Okayasu I
J Pathol; 2010 May; 221(1):26-36. PubMed ID: 20186924
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.
Geyer JT; López-García MA; Sánchez-Estevez C; Sarrió D; Moreno-Bueno G; Franceschetti I; Palacios J; Oliva E
Am J Surg Pathol; 2009 Aug; 33(8):1157-63. PubMed ID: 19542870
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
[TBL] [Abstract][Full Text] [Related]
8. Frequent inactivation of RUNX3 in endometrial carcinoma.
Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas.
Catasus L; Pons C; Muñoz J; Espinosa I; Prat J
Histopathology; 2013 Mar; 62(4):632-41. PubMed ID: 23379820
[TBL] [Abstract][Full Text] [Related]
11. Theories of endometrial carcinogenesis: a multidisciplinary approach.
Sherman ME
Mod Pathol; 2000 Mar; 13(3):295-308. PubMed ID: 10757340
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
Rodríguez-Jiménez FJ; Caldés T; Iniesta P; Vidart JA; Garcia-Asenjo JL; Benito M
Oncol Rep; 2007 Jun; 17(6):1301-7. PubMed ID: 17487382
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling.
Risinger JI; Maxwell GL; Chandramouli GV; Aprelikova O; Litzi T; Umar A; Berchuck A; Barrett JC
Cancer Res; 2005 Jun; 65(12):5031-7. PubMed ID: 15958545
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma.
Sakuragi N; Hirai A; Tada M; Yamada H; Yamamoto R; Fujimoto S; Moriuchi T
Gynecol Oncol; 2001 Dec; 83(3):485-90. PubMed ID: 11733960
[TBL] [Abstract][Full Text] [Related]
15. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma.
Modica I; Soslow RA; Black D; Tornos C; Kauff N; Shia J
Am J Surg Pathol; 2007 May; 31(5):744-51. PubMed ID: 17460459
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the homeodomain gene EMX2: sequence conservation, expression analysis, and a search for mutations in endometrial cancers.
Noonan FC; Mutch DG; Ann Mallon M; Goodfellow PJ
Genomics; 2001 Aug; 76(1-3):37-44. PubMed ID: 11549315
[TBL] [Abstract][Full Text] [Related]
17. High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.
Davalos V; Dopeso H; Velho S; Ferreira AM; Cirnes L; Díaz-Chico N; Bilbao C; Ramírez R; Rodríguez G; Falcón O; León L; Niessen RC; Keller G; Dallenbach-Hellweg G; Espín E; Armengol M; Plaja A; Perucho M; Imai K; Yamamoto H; Gebert JF; Díaz-Chico JC; Hofstra RM; Woerner SM; Seruca R; Schwartz S; Arango D
Oncogene; 2007 Jan; 26(2):308-11. PubMed ID: 16819508
[TBL] [Abstract][Full Text] [Related]
18. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.
Wappenschmidt B; Wardelmann E; Gehrig A; Schöndorf T; Maass N; Bonatz G; Gassel AM; Pietsch T; Mallmann P; Weber BH; Schmutzler RK
Hum Pathol; 2004 Oct; 35(10):1260-5. PubMed ID: 15492994
[TBL] [Abstract][Full Text] [Related]
19. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
[TBL] [Abstract][Full Text] [Related]
20. Molecular and pathologic aspects of endometrial carcinogenesis.
Hecht JL; Mutter GL
J Clin Oncol; 2006 Oct; 24(29):4783-91. PubMed ID: 17028294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]